News
As the U.S. approaches the midpoint of summer, the CDC is reporting cases of the virus are growing or likely growing in ...
The data, from the Centers for Disease Control and Prevention, also showed a significant increase in COVID-related emergency ...
The new shots won’t be available until the fall, and are expected to be approved only for adults 65 and up and kids and ...
COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it — the antiviral drug Paxlovid — is less clear. Research ...
COVID boosters reduced cancer patients’ hospitalizations and ICU stays by 29%, researchers report in JAMA Oncology. Overall, ...
One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.
Infants, toddlers and preschoolers exhibit symptoms of long COVID, but the symptoms can be different and more difficult to ...
Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results